Botulinum toxin type A in the treatment of hemifacial spasm: An 11-year experience;Toxina botulínica tipo A no tratamento do espasmo hemifacial: 11 anos de experiência

Arquivos de Neuro-Psiquiatria

Volumn 68, Issue 4, 2010, Pages 502-505

  Barbosa, Egberto Reis ^a   Takada, Leonel Tadao ^a   Gonçalves, Lilian Regina ^a   Costa, Rose Mary Paulo do Nascimento ^a   Silveira Moriyama, Laura ^b   Chien, Hsin Fen ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Botulinum toxin; Hemifacial spasm

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; BRAZIL; DRUG DOSE INCREASE; FEMALE; FOLLOW UP; HEMIFACIAL SPASM; HUMAN; LAGOPHTHALMOS; MAJOR CLINICAL STUDY; MALE; OPHTHALMOPLEGIA; ORBICULARIS ORIS MUSCLE; PTOSIS; RETROSPECTIVE STUDY; TREATMENT RESPONSE;

EID: 77957319320     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2010000400006     Document Type: Article

References (14)

1. Jitpimolmard S, Tiamkao S, Laopaiboon M. Long term results of botulinum 1. toxin type A (Dysport) in the treatment of hemifacial spasm: a report of 175 cases. J Neurol Neurosurg Psychiatry 1998;64:751-757.
2. Kenney C, Jankovic J. Botulinum toxin in the treatment of blepharospasm and hemifacial spasm. J Neural Transm 2008;115:585-591.
3. Greear Jr JN. Hemifacial spasm. Trans Am Ophthalmol Soc 1954-1955;52:3. 447-458.
4. Mauriello Jr JA, Leone T, Dhillon S, Pakeman B, Mostafavi R, Yepez MC. Treatment choices of 119 patients with hemifacial spasm over 11 years. Clin Neurol Neurosurg 1996;98:213-216.
5. Defazio G, Abbruzzese G, Girlanda P, et al. Botulinum toxin A treatment for primary hemifacial spasm. Arch Neurol 2002;59:418-420.
6. Hsiung G-YR, Das SK, Ranawaya R, Lafontaine AL, Suchowersky O. Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period. Mov Disord 2002;17:1288-1293.
7. Mejia NI, Vuong KD, Jankovic J. Long-term botulinum toxin efficacy, safety and immunogenicity. Mov Disord 2005;20:592-597.
8. Pérez-Saldaña MT, Parkhutik V, Boscá-Blasco ME, Claramonte B, Burguera-ernández JA. Espasmo hemifacial: más de 10 años de tratamiento com toxina botulínica. Rev Neurol 2007;45:582-586.
9. Consky E. Botulinum toxin injections in dystonias and hemifacial spasm. Wor-shop. Department of Neurology, Escola Paulista de Medicina. São Paulo (Brazil), October 3-4, 1991.
10. Brin M. BTX - chemistry, pharmacology, toxicity and imunology. American Academy of Neurology. Annual Courses Vol 2, 450:9-19, 1993.
11. Thussu A, Barman CR, Prabhakar S. Botulinum toxin treatment of hemifacial spasm and blepharospasm: objective response evaluation. Neurology (India) 1999;47:206-209.
12. Felicio AC, Godeiro Junior CdeO, Borges V, Silva SM, Ferraz HB. Clinical assessment of patients with primary and postparalytic hemifacial spasm: a retrospective study. Arq Neuropsiquiatr 2007;65:783-786.
13. Biglan AW, May M, Bowers RA. Management of facial spasm with clostridium botulinum toxin type A (Oculinum). Arch Otoryngol Head Neck Surg 1988;114:1407-1412.
14. Schellini SA, Matai O, Igami TZ, Padovani CR, Padovani CP. Essential blepharospasm and hemifacial spasm: characteristic of the patient, botulinum toxin A treatment and literature review. Arq Bras Oftalmol 2006;69:23-26.